Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Ktov Stock

Finance   Jun    Decline  High opportunity   


General search term.
Might be referring to: (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create successful long-lasting treatments for people with cancer.Dec 10, 2020.
This is a seasonal trend that repeats every June.
This trend is forecasted to be growing in the next 2 years.

  

Track this trend
(Monitor this trend over time)
 12 Months
Average: 6.92%
Trend: declining
MOM change: -0.14%
 5 Years
Average: 2.03%
Trend: declining
MOM change: -0.28%